Inner Mongolia Furui Med Sci (SHE:300049) — Market Cap & Net Worth
Market Cap & Net Worth: Inner Mongolia Furui Med Sci (300049)
Inner Mongolia Furui Med Sci (SHE:300049) has a market capitalization of $1.55 Billion (CN¥10.63 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #7228 globally and #1650 in its home market, demonstrating a -0.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inner Mongolia Furui Med Sci's stock price CN¥40.25 by its total outstanding shares 263991100 (263.99 Million). Review Inner Mongolia Furui Med Sci debt and liabilities to assess the company's total debt and financial obligations.
Inner Mongolia Furui Med Sci Market Cap History: 2015 to 2026
Inner Mongolia Furui Med Sci's market capitalization history from 2015 to 2026. Data shows growth from $1.17 Billion to $1.55 Billion (3.03% CAGR).
Inner Mongolia Furui Med Sci Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inner Mongolia Furui Med Sci's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.71x
Inner Mongolia Furui Med Sci's market cap is 1.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.65x
Inner Mongolia Furui Med Sci's market cap is 17.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $792.13 Million | $826.99 Million | $121.05 Million | 0.96x | 6.54x |
| 2017 | $507.82 Million | $823.33 Million | $61.11 Million | 0.62x | 8.31x |
| 2018 | $388.62 Million | $867.03 Million | $35.42 Million | 0.45x | 10.97x |
| 2019 | $291.28 Million | $831.74 Million | $43.39 Million | 0.35x | 6.71x |
| 2020 | $312.74 Million | $807.53 Million | $61.91 Million | 0.39x | 5.05x |
| 2021 | $563.39 Million | $898.48 Million | $95.47 Million | 0.63x | 5.90x |
| 2022 | $936.30 Million | $1.01 Billion | $97.89 Million | 0.93x | 9.56x |
| 2023 | $1.68 Billion | $1.15 Billion | $101.56 Million | 1.46x | 16.58x |
| 2024 | $1.22 Billion | $1.35 Billion | $113.29 Million | 0.90x | 10.76x |
| 2025 | $2.72 Billion | $1.59 Billion | $154.09 Million | 1.71x | 17.65x |
Competitor Companies of 300049 by Market Capitalization
Companies near Inner Mongolia Furui Med Sci in the global market cap rankings as of June 19, 2026.
Key companies related to Inner Mongolia Furui Med Sci by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.20 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €762.80 |
Inner Mongolia Furui Med Sci Historical Marketcap From 2015 to 2026
Between 2015 and today, Inner Mongolia Furui Med Sci's market cap moved from $1.17 Billion to $ 1.55 Billion, with a yearly change of 3.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.55 Billion | -42.83% |
| 2025 | CN¥2.72 Billion | +123.24% |
| 2024 | CN¥1.22 Billion | -27.64% |
| 2023 | CN¥1.68 Billion | +79.84% |
| 2022 | CN¥936.30 Million | +66.19% |
| 2021 | CN¥563.39 Million | +80.15% |
| 2020 | CN¥312.74 Million | +7.37% |
| 2019 | CN¥291.28 Million | -25.05% |
| 2018 | CN¥388.62 Million | -23.47% |
| 2017 | CN¥507.82 Million | -35.89% |
| 2016 | CN¥792.13 Million | -32.11% |
| 2015 | CN¥1.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Inner Mongolia Furui Med Sci was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.55 Billion USD |
| MoneyControl | $1.55 Billion USD |
| MarketWatch | $1.55 Billion USD |
| marketcap.company | $1.55 Billion USD |
| Reuters | $1.55 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liv… Read more